These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38287535)

  • 1. Correction to Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumours and differentiation from small intestinal neuroendocrine tumours. J Neuroendocrinol. 2022 Jul;34(7):e13176.
    J Neuroendocrinol; 2024 Mar; 36(3):e13368. PubMed ID: 38287535
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors.
    Thiis-Evensen E; Kjellman M; Knigge U; Gronbaek H; Schalin-Jäntti C; Welin S; Sorbye H; Del Pilar Schneider M; Belusa R;
    J Neuroendocrinol; 2022 Jul; 34(7):e13176. PubMed ID: 35829662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma or serum 5-hydroxyindoleacetic acid can be used interchangeably in patients with neuroendocrine tumours.
    Ewang-Emukowhate M; Subramaniam K; Lam F; Hayes A; Mandair D; Toumpanakis C; Grossman A; Nair D; Caplin M
    Scand J Clin Lab Invest; 2023 Dec; 83(8):576-581. PubMed ID: 38112030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of biochemical markers in the diagnosis of neuroendocrine tumours and for the follow-up of patients].
    Tőke J; Czirják G; Tóth M; Rácz K; Patócs A
    Orv Hetil; 2014 Nov; 155(45):1775-82. PubMed ID: 25362640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
    Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
    J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours.
    Rico K; Duan S; Pandey RL; Chen Y; Chakrabarti JT; Starr J; Zavros Y; Else T; Katona BW; Metz DC; Merchant JL
    BMJ Open Gastroenterol; 2021 Nov; 8(1):. PubMed ID: 34750164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
    Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
    Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours.
    Rehfeld JF; Broedbaek K; Goetze JP; Knigge U; Hilsted LM
    Scand J Gastroenterol; 2020 May; 55(5):565-573. PubMed ID: 32352887
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic value of plasma chromogranin A in neuroendocrine tumours.
    Tomassetti P; Migliori M; Simoni P; Casadei R; De Iasio R; Corinaldesi R; Gullo L
    Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):55-8. PubMed ID: 11204811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas.
    Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O
    J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy for neuroendocrine tumours].
    Tóth M
    Orv Hetil; 2013 Sep; 154(39):1556-64. PubMed ID: 24058101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of IL-8 and IL-8 receptors in pancreatic adenocarcinomas and pancreatic neuroendocrine tumours.
    Hussain F; Wang J; Ahmed R; Guest SK; Lam EW; Stamp G; El-Bahrawy M
    Cytokine; 2010 Feb; 49(2):134-40. PubMed ID: 20005738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.
    Jakobsen AM; Ahlman H; Kölby L; Abrahamsson J; Fischer-Colbrie R; Nilsson O
    Br J Cancer; 2003 Jun; 88(11):1746-54. PubMed ID: 12771991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
    J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours: a multicentre case series.
    Ho HC; Eloubeidi MA; Siddiqui UD; Brugge WR; Rossi F; Bounds BW; Aslanian HR
    Dig Liver Dis; 2013 Sep; 45(9):750-3. PubMed ID: 23582348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
    Roberts J; Gonzalez RS; Revetta F; Shi C
    Histopathology; 2018 Nov; 73(5):795-800. PubMed ID: 29943407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
    Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
    Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis BG; Casey RT; Grossman A; Newell-Price J; Newey P; Thakker RV
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):708-715. PubMed ID: 31505044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.